• Exchange: ASE
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

Benitec Biopharma Ltd

+ Add to Watchlist

BLT:AU

1.1300 AUD 0.0100 0.89%

As of 02:10:09 ET on 07/24/2014.

Snapshot for Benitec Biopharma Ltd (BLT)

Open: 1.1450 Day's Range: 1.1100 - 1.1500 Volume: 139,315
Previous Close: 1.1200 52wk Range: 0.2800 - 2.3800 1-Yr Rtn: +247.69%

Stock Chart for BLT

No chart data available.
  • BLT:AU 1.1300
  • 1D
  • 1M
  • 1Y
1.1200
Interactive BLT Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for BLT

Current P/E Ratio (ttm) -
Estimated P/E(06/2014) -
Relative P/E vs. AS51 -
Earnings Per Share (AUD) (ttm) -0.0411
Est. EPS (AUD) (06/2014) -0.0510
Est. PEG Ratio -
Market Cap (M AUD) 129.84
Shares Outstanding (M) 114.90
30 Day Average Volume 246,959
Price/Book (mrq) 81.3107
Price/Sale (ttm) 146.5869
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 09/01/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for BLT

  • Revenue
  • Net Income (M/AUD)
  • Profit Margin (%)

Company Profile & Key Executives for BLT

Benitec Biopharma Ltd. is a medical technology research and development Company. The Company's research focuses on the gene-technology field to find ways to fight cancer causing cells. Benitec's research encompasses a gene silencing technology in mammalian cells.

Peter FrenchCEO/Managing DirectorMichael W GrahamChief Scientific Officer
Carl S StubbingsChief Business OfficerDavid SuhySenior VP:Rsch & Dev
More Company Profile & Key Executives for BLT

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil